Mativ Holdings, Inc. Plans Quarterly Dividend of $0.10 (NYSE:MATV)

Mativ Holdings, Inc. (NYSE:MATV) declared a quarterly dividend on Wednesday, November 6th,NASDAQ Dividends reports. Shareholders of record on Friday, November 29th will be given a dividend of 0.10 per share on Friday, December 20th. This represents a $0.40 dividend on an annualized basis and a yield of 2.97%. The ex-dividend date of this dividend is Friday, November 29th.

Mativ has decreased its dividend payment by an average of 17.2% per year over the last three years. Mativ has a dividend payout ratio of 38.8% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Mativ to earn $1.15 per share next year, which means the company should continue to be able to cover its $0.40 annual dividend with an expected future payout ratio of 34.8%.

Mativ Trading Down 3.9 %

MATV stock opened at $13.47 on Wednesday. The company has a debt-to-equity ratio of 1.31, a current ratio of 2.37 and a quick ratio of 1.29. The company has a fifty day moving average price of $15.64 and a two-hundred day moving average price of $16.88. Mativ has a one year low of $10.78 and a one year high of $19.96. The stock has a market cap of $731.96 million, a price-to-earnings ratio of 6.87, a price-to-earnings-growth ratio of 3.89 and a beta of 0.70.

Analysts Set New Price Targets

Separately, Stifel Nicolaus began coverage on shares of Mativ in a research report on Thursday, November 21st. They set a “hold” rating and a $15.50 price objective for the company.

Mativ Company Profile

Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.